Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

3 giugno 2014 aggiornato da: Boehringer Ingelheim

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed the RE-LY Trial and a Cluster Randomised Trial to Assess the Effect of a Knowledge Translation Intervention on Patient Outcomes

The purposes of this study are:

  1. To evaluate the long-term safety of dabigatran etexilate
  2. To assess the effect of a knowledge translation intervention on patient outcomes

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Effettivo)

5897

Fase

  • Fase 3

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

  • Australia
    • New South Wales
      • Coffs Harbour, New South Wales, Australia
        • 1160.71.0508 Boehringer Ingelheim Investigational Site
      • Gosford, New South Wales, Australia
        • 1160.71.0510 Boehringer Ingelheim Investigational Site
    • Queensland
      • Milton, Queensland, Australia
        • 1160.71.0506 Boehringer Ingelheim Investigational Site
    • South Australia
      • Ashford, South Australia, Australia
        • 1160.71.0509 Boehringer Ingelheim Investigational Site
    • Tasmania
      • Launceston, Tasmania, Australia
        • 1160.71.0507 Boehringer Ingelheim Investigational Site
    • Victoria
      • Box Hill, Victoria, Australia
        • 1160.71.0504 Boehringer Ingelheim Investigational Site
      • Geelong, Victoria, Australia
        • 1160.71.0501 Boehringer Ingelheim Investigational Site
  • Austria
      • Graz, Austria
        • 1160.71.0543 Boehringer Ingelheim Investigational Site
      • Linz, Austria
        • 1160.71.0549 Boehringer Ingelheim Investigational Site
      • Wien, Austria
        • 1160.71.0541 Boehringer Ingelheim Investigational Site
      • Wien, Austria
        • 1160.71.0542 Boehringer Ingelheim Investigational Site
      • Wien, Austria
        • 1160.71.0545 Boehringer Ingelheim Investigational Site
      • Wien, Austria
        • 1160.71.0547 Boehringer Ingelheim Investigational Site
      • Wien, Austria
        • 1160.71.0548 Boehringer Ingelheim Investigational Site
      • Wr. Neustadt, Austria
        • 1160.71.0550 Boehringer Ingelheim Investigational Site
  • Belgio
      • Aalst, Belgio
        • 1160.71.0564 Boehringer Ingelheim Investigational Site
      • Brasschaat, Belgio
        • 1160.71.0572 Boehringer Ingelheim Investigational Site
      • Brussel, Belgio
        • 1160.71.0571 Boehringer Ingelheim Investigational Site
      • Bruxelles, Belgio
        • 1160.71.0581 Boehringer Ingelheim Investigational Site
      • Bruxelles, Belgio
        • 1160.71.0585 Boehringer Ingelheim Investigational Site
      • Edegem, Belgio
        • 1160.71.0563 Boehringer Ingelheim Investigational Site
      • Genk, Belgio
        • 1160.71.0578 Boehringer Ingelheim Investigational Site
      • Genk, Belgio
        • 1160.71.0587 Boehringer Ingelheim Investigational Site
      • Gent, Belgio
        • 1160.71.0574 Boehringer Ingelheim Investigational Site
      • Gilly, Belgio
        • 1160.71.0588 Boehringer Ingelheim Investigational Site
      • Hasselt, Belgio
        • 1160.71.0568 Boehringer Ingelheim Investigational Site
      • Leuven, Belgio
        • 1160.71.0561 Boehringer Ingelheim Investigational Site
      • Liège, Belgio
        • 1160.71.0579 Boehringer Ingelheim Investigational Site
      • Oostende, Belgio
        • 1160.71.0567 Boehringer Ingelheim Investigational Site
      • Roeselare, Belgio
        • 1160.71.0570 Boehringer Ingelheim Investigational Site
      • Tienen, Belgio
        • 1160.71.0566 Boehringer Ingelheim Investigational Site
      • Turnhout, Belgio
        • 1160.71.0562 Boehringer Ingelheim Investigational Site
  • Brasile
      • Campinas, Brasile
        • 1160.71.0644 Boehringer Ingelheim Investigational Site
      • Curitiba, Brasile
        • 1160.71.0650 Boehringer Ingelheim Investigational Site
      • Curitiba, Brasile
        • 1160.71.0651 Boehringer Ingelheim Investigational Site
      • Goiania, Brasile
        • 1160.71.0652 Boehringer Ingelheim Investigational Site
      • Sao Jose do Riio Preto, Brasile
        • 1160.71.0646 Boehringer Ingelheim Investigational Site
      • São José do Rio Preto, Brasile
        • 1160.71.0647 Boehringer Ingelheim Investigational Site
      • São Paulo, Brasile
        • 1160.71.0643 Boehringer Ingelheim Investigational Site
  • Bulgaria
      • Pleven, Bulgaria
        • 1160.71.0620 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgaria
        • 1160.71.0611 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgaria
        • 1160.71.0612 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgaria
        • 1160.71.0615 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgaria
        • 1160.71.0617 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgaria
        • 1160.71.0618 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgaria
        • 1160.71.0625 Boehringer Ingelheim Investigational Site
  • Canada
      • Quebec, Canada
        • 1160.71.0700 Boehringer Ingelheim Investigational Site
    • Alberta
      • Calgary, Alberta, Canada
        • 1160.71.0694 Boehringer Ingelheim Investigational Site
      • Calgary, Alberta, Canada
        • 1160.71.0696 Boehringer Ingelheim Investigational Site
    • British Columbia
      • Coquitlam, British Columbia, Canada
        • 1160.71.0680 Boehringer Ingelheim Investigational Site
      • Coquitlam, British Columbia, Canada
        • 1160.71.0712 Boehringer Ingelheim Investigational Site
      • Kelowna, British Columbia, Canada
        • 1160.71.0706 Boehringer Ingelheim Investigational Site
      • Nanaimo, British Columbia, Canada
        • 1160.71.0725 Boehringer Ingelheim Investigational Site
      • New Westminster, British Columbia, Canada
        • 1160.71.0691 Boehringer Ingelheim Investigational Site
      • Victoria, British Columbia, Canada
        • 1160.71.0714 Boehringer Ingelheim Investigational Site
    • Manitoba
      • Portage la Prairie, Manitoba, Canada
        • 1160.71.0701 Boehringer Ingelheim Investigational Site
    • Nova Scotia
      • Halifax, Nova Scotia, Canada
        • 1160.71.0703 Boehringer Ingelheim Investigational Site
    • Ontario
      • Burlington, Ontario, Canada
        • 1160.71.0674 Boehringer Ingelheim Investigational Site
      • Cambridge, Ontario, Canada
        • 1160.71.0702 Boehringer Ingelheim Investigational Site
      • Cambridge, Ontario, Canada
        • 1160.71.0720 Boehringer Ingelheim Investigational Site
      • Grimsby, Ontario, Canada
        • 1160.71.0692 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 1160.71.0697 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 1160.71.0710 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 1160.71.0719 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 1160.71.0721 Boehringer Ingelheim Investigational Site
      • Mississauga, Ontario, Canada
        • 1160.71.0708 Boehringer Ingelheim Investigational Site
      • Newmarket, Ontario, Canada
        • 1160.71.0688 Boehringer Ingelheim Investigational Site
      • Oshawa, Ontario, Canada
        • 1160.71.0672 Boehringer Ingelheim Investigational Site
      • Ottawa, Ontario, Canada
        • 1160.71.0687 Boehringer Ingelheim Investigational Site
      • Scarborough, Ontario, Canada
        • 1160.71.0679 Boehringer Ingelheim Investigational Site
      • Scarborough, Ontario, Canada
        • 1160.71.0723 Boehringer Ingelheim Investigational Site
      • Sudbury, Ontario, Canada
        • 1160.71.0715 Boehringer Ingelheim Investigational Site
      • Thunder Bay, Ontario, Canada
        • 1160.71.0690 Boehringer Ingelheim Investigational Site
      • Toronto, Ontario, Canada
        • 1160.71.0684 Boehringer Ingelheim Investigational Site
      • Toronto, Ontario, Canada
        • 1160.71.0718 Boehringer Ingelheim Investigational Site
      • Windsor, Ontario, Canada
        • 1160.71.0686 Boehringer Ingelheim Investigational Site
    • Quebec
      • Montreal, Quebec, Canada
        • 1160.71.0683 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 1160.71.0705 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 1160.71.0709 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 1160.71.0716 Boehringer Ingelheim Investigational Site
      • Quebec City, Quebec, Canada
        • 1160.71.0717 Boehringer Ingelheim Investigational Site
      • St. Charles-Borromee, Quebec, Canada
        • 1160.71.0699 Boehringer Ingelheim Investigational Site
      • St. George-de-Beauce, Quebec, Canada
        • 1160.71.0713 Boehringer Ingelheim Investigational Site
      • St. Hyacinthe, Quebec, Canada
        • 1160.71.0675 Boehringer Ingelheim Investigational Site
    • Saskatchewan
      • Saskatoon, Saskatchewan, Canada
        • 1160.71.0673 Boehringer Ingelheim Investigational Site
      • Saskatoon, Saskatchewan, Canada
        • 1160.71.0678 Boehringer Ingelheim Investigational Site
  • Cina
      • Beijing, Cina
        • 1160.71.0771 Boehringer Ingelheim Investigational Site
      • Beijing, Cina
        • 1160.71.0772 Boehringer Ingelheim Investigational Site
      • Beijing, Cina
        • 1160.71.0773 Boehringer Ingelheim Investigational Site
      • Beijing, Cina
        • 1160.71.0774 Boehringer Ingelheim Investigational Site
      • Haerbin, Cina
        • 1160.71.0776 Boehringer Ingelheim Investigational Site
      • Hangzhou, Cina
        • 1160.71.0784 Boehringer Ingelheim Investigational Site
      • QingDao, Cina
        • 1160.71.0778 Boehringer Ingelheim Investigational Site
      • Shanghai, Cina
        • 1160.71.0781 Boehringer Ingelheim Investigational Site
      • Shanghai, Cina
        • 1160.71.0782 Boehringer Ingelheim Investigational Site
      • Shenyang, Cina
        • 1160.71.0777 Boehringer Ingelheim Investigational Site
      • Shijiazhuang, Cina
        • 1160.71.0780 Boehringer Ingelheim Investigational Site
  • Corea, Repubblica di
      • Busan, Corea, Repubblica di
        • 1160.71.1585 Boehringer Ingelheim Investigational Site
      • Cheonan-si, Corea, Repubblica di
        • 1160.71.1586 Boehringer Ingelheim Investigational Site
      • Daegu, Corea, Repubblica di
        • 1160.71.1584 Boehringer Ingelheim Investigational Site
      • Daegu, Corea, Repubblica di
        • 1160.71.1591 Boehringer Ingelheim Investigational Site
      • Gwangju, Corea, Repubblica di
        • 1160.71.1590 Boehringer Ingelheim Investigational Site
      • Incheon, Corea, Repubblica di
        • 1160.71.1581 Boehringer Ingelheim Investigational Site
      • Seoul, Corea, Repubblica di
        • 1160.71.1582 Boehringer Ingelheim Investigational Site
      • Seoul, Corea, Repubblica di
        • 1160.71.1583 Boehringer Ingelheim Investigational Site
      • Seoul, Corea, Repubblica di
        • 1160.71.1589 Boehringer Ingelheim Investigational Site
      • Seoul, Corea, Repubblica di
        • 1160.71.1592 Boehringer Ingelheim Investigational Site
      • Seoul, Corea, Repubblica di
        • 1160.71.1593 Boehringer Ingelheim Investigational Site
  • Danimarca
      • Aalborg, Danimarca
        • 1160.71.0837 Boehringer Ingelheim Investigational Site
      • Aarhus C, Danimarca
        • 1160.71.0835 Boehringer Ingelheim Investigational Site
      • Frederikssund, Danimarca
        • 1160.71.0838 Boehringer Ingelheim Investigational Site
      • Helsingør, Danimarca
        • 1160.71.0833 Boehringer Ingelheim Investigational Site
      • Herlev, Danimarca
        • 1160.71.0834 Boehringer Ingelheim Investigational Site
      • Horsens, Danimarca
        • 1160.71.0841 Boehringer Ingelheim Investigational Site
      • Hvidovre, Danimarca
        • 1160.71.0832 Boehringer Ingelheim Investigational Site
      • Køge, Danimarca
        • 1160.71.0840 Boehringer Ingelheim Investigational Site
      • Odense, Danimarca
        • 1160.71.0831 Boehringer Ingelheim Investigational Site
      • Roskilde, Danimarca
        • 1160.71.0839 Boehringer Ingelheim Investigational Site
      • Svendborg, Danimarca
        • 1160.71.0836 Boehringer Ingelheim Investigational Site
  • Federazione Russa
      • Moscow, Federazione Russa
        • 1160.71.1501 Boehringer Ingelheim Investigational Site
      • Moscow, Federazione Russa
        • 1160.71.1503 Boehringer Ingelheim Investigational Site
      • Moscow, Federazione Russa
        • 1160.71.1504 Boehringer Ingelheim Investigational Site
      • Moscow, Federazione Russa
        • 1160.71.1505 Boehringer Ingelheim Investigational Site
      • Moscow, Federazione Russa
        • 1160.71.1507 Boehringer Ingelheim Investigational Site
      • Moscow, Federazione Russa
        • 1160.71.1508 Boehringer Ingelheim Investigational Site
      • Moscow, Federazione Russa
        • 1160.71.1509 Boehringer Ingelheim Investigational Site
      • Moscow, Federazione Russa
        • 1160.71.1510 Boehringer Ingelheim Investigational Site
      • Moscow, Federazione Russa
        • 1160.71.1511 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Federazione Russa
        • 1160.71.1512 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Federazione Russa
        • 1160.71.1513 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Federazione Russa
        • 1160.71.1514 Boehringer Ingelheim Investigational Site
  • Filippine
      • Ermita Manila, Filippine
        • 1160.71.1422 Boehringer Ingelheim Investigational Site
      • Manila, Filippine
        • 1160.71.1421 Boehringer Ingelheim Investigational Site
      • Pasig City, Filippine
        • 1160.71.1424 Boehringer Ingelheim Investigational Site
      • Quezon City, Filippine
        • 1160.71.1423 Boehringer Ingelheim Investigational Site
      • Quezon City, Filippine
        • 1160.71.1425 Boehringer Ingelheim Investigational Site
  • Finlandia
      • Helsinki, Finlandia
        • 1160.71.0851 Boehringer Ingelheim Investigational Site
      • Jyväskylä, Finlandia
        • 1160.71.0859 Boehringer Ingelheim Investigational Site
      • Oulu, Finlandia
        • 1160.71.0854 Boehringer Ingelheim Investigational Site
      • Pori, Finlandia
        • 1160.71.0858 Boehringer Ingelheim Investigational Site
      • Tampere, Finlandia
        • 1160.71.0852 Boehringer Ingelheim Investigational Site
      • Turku, Finlandia
        • 1160.71.0853 Boehringer Ingelheim Investigational Site
  • Francia
      • ABBEVILLE cedex, Francia
        • 1160.71.875A Boehringer Ingelheim Investigational Site
      • Angers, Francia
        • 1160.71.882D Boehringer Ingelheim Investigational Site
      • Angers, Francia
        • 1160.71.882G Boehringer Ingelheim Investigational Site
      • Besle Sur Vilaine, Francia
        • 1160.71.879F Boehringer Ingelheim Investigational Site
      • Cholet, Francia
        • 1160.71.887A Boehringer Ingelheim Investigational Site
      • Château Gontier, Francia
        • 1160.71.882K Boehringer Ingelheim Investigational Site
      • Derval, Francia
        • 1160.71.879C Boehringer Ingelheim Investigational Site
      • Feneu, Francia
        • 1160.71.882H Boehringer Ingelheim Investigational Site
      • GRENOBLE Cédex 9, Francia
        • 1160.71.888A Boehringer Ingelheim Investigational Site
      • La Chapelle sur Erdre, Francia
        • 1160.71.879B Boehringer Ingelheim Investigational Site
      • Langres, Francia
        • 1160.71.874A Boehringer Ingelheim Investigational Site
      • Laval, Francia
        • 1160.71.884A Boehringer Ingelheim Investigational Site
      • Le Mesnil en Valée, Francia
        • 1160.71.880B Boehringer Ingelheim Investigational Site
      • Murs Erigne, Francia
        • 1160.71.880A Boehringer Ingelheim Investigational Site
      • Nantes, Francia
        • 1160.71.879A Boehringer Ingelheim Investigational Site
      • Nantes, Francia
        • 1160.71.879H Boehringer Ingelheim Investigational Site
      • Nantes, Francia
        • 1160.71.879S Boehringer Ingelheim Investigational Site
      • Parcay les Pins, Francia
        • 1160.71.880J Boehringer Ingelheim Investigational Site
      • Paris, Francia
        • 1160.71.871A Boehringer Ingelheim Investigational Site
      • Saint Aubin Des Chateaux, Francia
        • 1160.71.879E Boehringer Ingelheim Investigational Site
      • Segre, Francia
        • 1160.71.880D Boehringer Ingelheim Investigational Site
      • Tierce, Francia
        • 1160.71.882A Boehringer Ingelheim Investigational Site
      • Tierce, Francia
        • 1160.71.882B Boehringer Ingelheim Investigational Site
      • Tierce, Francia
        • 1160.71.882C Boehringer Ingelheim Investigational Site
      • Vieillevigne, Francia
        • 1160.71.879G Boehringer Ingelheim Investigational Site
      • Vihiers, Francia
        • 1160.71.880E Boehringer Ingelheim Investigational Site
  • Germania
      • Berlin, Germania
        • 1160.71.0932 Boehringer Ingelheim Investigational Site
      • Berlin, Germania
        • 1160.71.0948 Boehringer Ingelheim Investigational Site
      • Berlin, Germania
        • 1160.71.0962 Boehringer Ingelheim Investigational Site
      • Bochum, Germania
        • 1160.71.0940 Boehringer Ingelheim Investigational Site
      • Dortmund, Germania
        • 1160.71.0972 Boehringer Ingelheim Investigational Site
      • Essen, Germania
        • 1160.71.0934 Boehringer Ingelheim Investigational Site
      • Frankfurt am Main, Germania
        • 1160.71.0931 Boehringer Ingelheim Investigational Site
      • Heidelberg, Germania
        • 1160.71.0943 Boehringer Ingelheim Investigational Site
      • Köln, Germania
        • 1160.71.0963 Boehringer Ingelheim Investigational Site
      • Lahr, Germania
        • 1160.71.0946 Boehringer Ingelheim Investigational Site
      • Limburg, Germania
        • 1160.71.0944 Boehringer Ingelheim Investigational Site
      • Mainz, Germania
        • 1160.71.0951 Boehringer Ingelheim Investigational Site
      • Mannheim, Germania
        • 1160.71.0933 Boehringer Ingelheim Investigational Site
      • Mannheim, Germania
        • 1160.71.0945 Boehringer Ingelheim Investigational Site
      • Mannheim, Germania
        • 1160.71.0970 Boehringer Ingelheim Investigational Site
      • Witten, Germania
        • 1160.71.0937 Boehringer Ingelheim Investigational Site
      • Wuppertal, Germania
        • 1160.71.0966 Boehringer Ingelheim Investigational Site
  • Grecia
      • Athens, Grecia
        • 1160.71.0901 Boehringer Ingelheim Investigational Site
      • Kalamaria-Thessaloniki, Grecia
        • 1160.71.0914 Boehringer Ingelheim Investigational Site
      • Larissa, Grecia
        • 1160.71.0904 Boehringer Ingelheim Investigational Site
      • Thiva, Grecia
        • 1160.71.0910 Boehringer Ingelheim Investigational Site
      • Trikala, Grecia
        • 1160.71.0903 Boehringer Ingelheim Investigational Site
      • Voula - Athens, Grecia
        • 1160.71.0905 Boehringer Ingelheim Investigational Site
  • Hong Kong
      • Kowloon, Hong Kong
        • 1160.71.1003 Boehringer Ingelheim Investigational Site
      • Kowloon, Hong Kong
        • 1160.71.1004 Boehringer Ingelheim Investigational Site
  • India
      • Ahmedabad, India
        • 1160.71.1057 Boehringer Ingelheim Investigational Site
      • Ahmedabad-52, India
        • 1160.71.1056 Boehringer Ingelheim Investigational Site
      • Bangalore, India
        • 1160.71.1065 Boehringer Ingelheim Investigational Site
      • Hyderabad, India
        • 1160.71.1062 Boehringer Ingelheim Investigational Site
      • Jaipur, Rajasthan, India
        • 1160.71.1073 Boehringer Ingelheim Investigational Site
      • Kerala, India
        • 1160.71.1067 Boehringer Ingelheim Investigational Site
      • Kottayam, India
        • 1160.71.1068 Boehringer Ingelheim Investigational Site
      • Lucknow, Uttar Pradesh, India
        • 1160.71.1055 Boehringer Ingelheim Investigational Site
      • Ludhiana, India
        • 1160.71.1051 Boehringer Ingelheim Investigational Site
      • Mysore, India
        • 1160.71.1072 Boehringer Ingelheim Investigational Site
      • Nagpur-12, India
        • 1160.71.1059 Boehringer Ingelheim Investigational Site
      • New Delhi, India
        • 1160.71.1052 Boehringer Ingelheim Investigational Site
      • Pune, Maharashtra, India
        • 1160.71.1070 Boehringer Ingelheim Investigational Site
  • Israele
      • Afula, Israele
        • 1160.71.1110 Boehringer Ingelheim Investigational Site
      • Afula, Israele
        • 1160.71.1121 Boehringer Ingelheim Investigational Site
      • Ashkelon, Israele
        • 1160.71.1111 Boehringer Ingelheim Investigational Site
      • Givatayim, Israele
        • 1160.71.1117 Boehringer Ingelheim Investigational Site
      • Hadera, Israele
        • 1160.71.1112 Boehringer Ingelheim Investigational Site
      • Haifa, Israele
        • 1160.71.1091 Boehringer Ingelheim Investigational Site
      • Haifa, Israele
        • 1160.71.1113 Boehringer Ingelheim Investigational Site
      • Haifa, Israele
        • 1160.71.1114 Boehringer Ingelheim Investigational Site
      • Haifa, Israele
        • 1160.71.1116 Boehringer Ingelheim Investigational Site
      • Haifa, Israele
        • 1160.71.1118 Boehringer Ingelheim Investigational Site
      • Holon, Israele
        • 1160.71.1105 Boehringer Ingelheim Investigational Site
      • Jerusalem, Israele
        • 1160.71.1101 Boehringer Ingelheim Investigational Site
      • Jerusalem, Israele
        • 1160.71.1104 Boehringer Ingelheim Investigational Site
      • Jerusalem, Israele
        • 1160.71.1106 Boehringer Ingelheim Investigational Site
      • Kfar Saba, Israele
        • 1160.71.1119 Boehringer Ingelheim Investigational Site
      • Petah Tikva, Israele
        • 1160.71.1096 Boehringer Ingelheim Investigational Site
      • Ramat Gan, Israele
        • 1160.71.1093 Boehringer Ingelheim Investigational Site
      • Ramat Gan, Israele
        • 1160.71.1094 Boehringer Ingelheim Investigational Site
      • Ramat Gan, Israele
        • 1160.71.1095 Boehringer Ingelheim Investigational Site
      • Rehovot, Israele
        • 1160.71.1100 Boehringer Ingelheim Investigational Site
      • Safed, Israele
        • 1160.71.1103 Boehringer Ingelheim Investigational Site
      • Tel Aviv, Israele
        • 1160.71.1120 Boehringer Ingelheim Investigational Site
      • Tel Aviv, Israele
        • 1160.71.1122 Boehringer Ingelheim Investigational Site
      • Tel-Aviv, Israele
        • 1160.71.1107 Boehringer Ingelheim Investigational Site
      • Tel-Aviv, Israele
        • 1160.71.1108 Boehringer Ingelheim Investigational Site
      • Tel-Aviv, Israele
        • 1160.71.1109 Boehringer Ingelheim Investigational Site
  • Italia
      • Arezzo, Italia
        • 1160.71.1169 Boehringer Ingelheim Investigational Site
      • Ascoli Piceno, Italia
        • 1160.71.1172 Boehringer Ingelheim Investigational Site
      • Sassari, Italia
        • 1160.71.1170 Boehringer Ingelheim Investigational Site
  • Malaysia
      • Kuala Lumpur, Malaysia
        • 1160.71.1291 Boehringer Ingelheim Investigational Site
      • Kuala Lumpur, Malaysia
        • 1160.71.1292 Boehringer Ingelheim Investigational Site
  • Norvegia
      • Gjøvik, Norvegia
        • 1160.71.1396 Boehringer Ingelheim Investigational Site
      • Moss, Norvegia
        • 1160.71.1393 Boehringer Ingelheim Investigational Site
      • Nordbyhagen, Norvegia
        • 1160.71.1395 Boehringer Ingelheim Investigational Site
      • Oslo, Norvegia
        • 1160.71.1391 Boehringer Ingelheim Investigational Site
      • Oslo, Norvegia
        • 1160.71.1397 Boehringer Ingelheim Investigational Site
      • RUD, Norvegia
        • 1160.71.1394 Boehringer Ingelheim Investigational Site
  • Olanda
      • 's Hertogenbosch, Olanda
        • 1160.71.1337 Boehringer Ingelheim Investigational Site
      • Almelo, Olanda
        • 1160.71.1344 Boehringer Ingelheim Investigational Site
      • Amsterdam, Olanda
        • 1160.71.1331 Boehringer Ingelheim Investigational Site
      • Apeldoorn, Olanda
        • 1160.71.1336 Boehringer Ingelheim Investigational Site
      • Breda, Olanda
        • 1160.71.1332 Boehringer Ingelheim Investigational Site
      • Den Helder, Olanda
        • 1160.71.1349 Boehringer Ingelheim Investigational Site
      • Deventer, Olanda
        • 1160.71.1345 Boehringer Ingelheim Investigational Site
      • Dirksland, Olanda
        • 1160.71.1360 Boehringer Ingelheim Investigational Site
      • Ede, Olanda
        • 1160.71.1340 Boehringer Ingelheim Investigational Site
      • Eindhoven, Olanda
        • 1160.71.1358 Boehringer Ingelheim Investigational Site
      • Enschede, Olanda
        • 1160.71.1338 Boehringer Ingelheim Investigational Site
      • Goes, Olanda
        • 1160.71.1343 Boehringer Ingelheim Investigational Site
      • Gorinchem, Olanda
        • 1160.71.1347 Boehringer Ingelheim Investigational Site
      • Groningen, Olanda
        • 1160.71.1333 Boehringer Ingelheim Investigational Site
      • Heerlen, Olanda
        • 1160.71.1361 Boehringer Ingelheim Investigational Site
      • Hengelo, Olanda
        • 1160.71.1339 Boehringer Ingelheim Investigational Site
      • Hilversum, Olanda
        • 1160.71.1346 Boehringer Ingelheim Investigational Site
      • Hoorn, Olanda
        • 1160.71.1356 Boehringer Ingelheim Investigational Site
      • Maastricht, Olanda
        • 1160.71.1359 Boehringer Ingelheim Investigational Site
      • Meppel, Olanda
        • 1160.71.1341 Boehringer Ingelheim Investigational Site
      • Rotterdam, Olanda
        • 1160.71.1354 Boehringer Ingelheim Investigational Site
      • Sneek, Olanda
        • 1160.71.1351 Boehringer Ingelheim Investigational Site
      • Tiel, Olanda
        • 1160.71.1353 Boehringer Ingelheim Investigational Site
      • Tilburg, Olanda
        • 1160.71.1352 Boehringer Ingelheim Investigational Site
      • Veldhoven, Olanda
        • 1160.71.1350 Boehringer Ingelheim Investigational Site
      • Velp, Olanda
        • 1160.71.1342 Boehringer Ingelheim Investigational Site
      • Zwijndrecht, Olanda
        • 1160.71.1348 Boehringer Ingelheim Investigational Site
  • Polonia
      • Gdynia, Polonia
        • 1160.71.1436 Boehringer Ingelheim Investigational Site
      • Gdynia, Polonia
        • 1160.71.1437 Boehringer Ingelheim Investigational Site
      • Gdynia, Polonia
        • 1160.71.1438 Boehringer Ingelheim Investigational Site
      • Pulawy, Polonia
        • 1160.71.1433 Boehringer Ingelheim Investigational Site
      • Warsaw, Polonia
        • 1160.71.1431 Boehringer Ingelheim Investigational Site
      • Warsaw, Polonia
        • 1160.71.1432 Boehringer Ingelheim Investigational Site
      • Zabrze, Polonia
        • 1160.71.1434 Boehringer Ingelheim Investigational Site
  • Portogallo
      • Amadora, Portogallo
        • 1160.71.1456 Boehringer Ingelheim Investigational Site
      • Carnaxide, Portogallo
        • 1160.71.1451 Boehringer Ingelheim Investigational Site
      • Coimbra, Portogallo
        • 1160.71.1454 Boehringer Ingelheim Investigational Site
      • Coimbra, Portogallo
        • 1160.71.1459 Boehringer Ingelheim Investigational Site
      • Covilhã, Portogallo
        • 1160.71.1457 Boehringer Ingelheim Investigational Site
      • Porto, Portogallo
        • 1160.71.1455 Boehringer Ingelheim Investigational Site
  • Regno Unito
      • Birmingham, Regno Unito
        • 1160.71.1744 Boehringer Ingelheim Investigational Site
      • Chertsey, Regno Unito
        • 1160.71.1746 Boehringer Ingelheim Investigational Site
      • County Armagh, Regno Unito
        • 1160.71.1745 Boehringer Ingelheim Investigational Site
      • Kirkcaldy, Fife, Regno Unito
        • 1160.71.1755 Boehringer Ingelheim Investigational Site
      • London, Regno Unito
        • 1160.71.1741 Boehringer Ingelheim Investigational Site
      • Newcastle upon Tyne, Regno Unito
        • 1160.71.1742 Boehringer Ingelheim Investigational Site
      • Newport, Regno Unito
        • 1160.71.1751 Boehringer Ingelheim Investigational Site
      • Northampton, Regno Unito
        • 1160.71.1752 Boehringer Ingelheim Investigational Site
      • Romford, Essex, Regno Unito
        • 1160.71.1743 Boehringer Ingelheim Investigational Site
      • York, Regno Unito
        • 1160.71.1748 Boehringer Ingelheim Investigational Site
  • Repubblica Ceca
      • Modrice, Repubblica Ceca
        • 1160.71.0816 Boehringer Ingelheim Investigational Site
      • Ostrava 1, Repubblica Ceca
        • 1160.71.0820 Boehringer Ingelheim Investigational Site
      • Pardubice, Repubblica Ceca
        • 1160.71.0818 Boehringer Ingelheim Investigational Site
      • Plzen-Bory, Repubblica Ceca
        • 1160.71.0814 Boehringer Ingelheim Investigational Site
      • Praha 5, Repubblica Ceca
        • 1160.71.0811 Boehringer Ingelheim Investigational Site
      • Praha 6, Repubblica Ceca
        • 1160.71.0812 Boehringer Ingelheim Investigational Site
      • Praha 9, Repubblica Ceca
        • 1160.71.0813 Boehringer Ingelheim Investigational Site
      • Pribram, Repubblica Ceca
        • 1160.71.0817 Boehringer Ingelheim Investigational Site
      • Usti nad Orlici, Repubblica Ceca
        • 1160.71.0819 Boehringer Ingelheim Investigational Site
  • Romania
      • Bucharest, Romania
        • 1160.71.1471 Boehringer Ingelheim Investigational Site
      • Bucharest, Romania
        • 1160.71.1472 Boehringer Ingelheim Investigational Site
  • Singapore
      • Singapore, Singapore
        • 1160.71.1531 Boehringer Ingelheim Investigational Site
  • Slovacchia
      • Banska Bystrica, Slovacchia
        • 1160.71.1548 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovacchia
        • 1160.71.1541 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovacchia
        • 1160.71.1542 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovacchia
        • 1160.71.1543 Boehringer Ingelheim Investigational Site
      • Kosice, Slovacchia
        • 1160.71.1550 Boehringer Ingelheim Investigational Site
      • Zilina, Slovacchia
        • 1160.71.1547 Boehringer Ingelheim Investigational Site
  • Stati Uniti
    • Alabama
      • Birmingham, Alabama, Stati Uniti
        • 1160.71.0046 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Stati Uniti
        • 1160.71.0057 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Stati Uniti
        • 1160.71.0211 Boehringer Ingelheim Investigational Site
      • Mobile, Alabama, Stati Uniti
        • 1160.71.0115 Boehringer Ingelheim Investigational Site
    • Arizona
      • Lake Havasu City, Arizona, Stati Uniti
        • 1160.71.0104 Boehringer Ingelheim Investigational Site
      • Tucson, Arizona, Stati Uniti
        • 1160.71.0185 Boehringer Ingelheim Investigational Site
    • Arkansas
      • Hot Springs, Arkansas, Stati Uniti
        • 1160.71.0038 Boehringer Ingelheim Investigational Site
      • Jonesboro, Arkansas, Stati Uniti
        • 1160.71.0302 Boehringer Ingelheim Investigational Site
      • Little Rock, Arkansas, Stati Uniti
        • 1160.71.0191 Boehringer Ingelheim Investigational Site
      • Little Rock, Arkansas, Stati Uniti
        • 1160.71.0213 Boehringer Ingelheim Investigational Site
    • California
      • Carmichael, California, Stati Uniti
        • 1160.71.0441 Boehringer Ingelheim Investigational Site
      • Fullerton, California, Stati Uniti
        • 1160.71.0333 Boehringer Ingelheim Investigational Site
      • La Jolla, California, Stati Uniti
        • 1160.71.0384 Boehringer Ingelheim Investigational Site
      • Lancaster, California, Stati Uniti
        • 1160.71.0246 Boehringer Ingelheim Investigational Site
      • Merced, California, Stati Uniti
        • 1160.71.0070 Boehringer Ingelheim Investigational Site
      • Oakland, California, Stati Uniti
        • 1160.71.0349 Boehringer Ingelheim Investigational Site
      • Oceanside, California, Stati Uniti
        • 1160.71.0016 Boehringer Ingelheim Investigational Site
      • Pasadena, California, Stati Uniti
        • 1160.71.0459 Boehringer Ingelheim Investigational Site
      • Poway, California, Stati Uniti
        • 1160.71.0270 Boehringer Ingelheim Investigational Site
      • Riverside, California, Stati Uniti
        • 1160.71.0135 Boehringer Ingelheim Investigational Site
      • Sacramento, California, Stati Uniti
        • 1160.71.0300 Boehringer Ingelheim Investigational Site
      • San Diego, California, Stati Uniti
        • 1160.71.0284 Boehringer Ingelheim Investigational Site
      • Walnut Creek, California, Stati Uniti
        • 1160.71.0379 Boehringer Ingelheim Investigational Site
    • Colorado
      • Colorado Springs, Colorado, Stati Uniti
        • 1160.71.0321 Boehringer Ingelheim Investigational Site
      • Colorado Springs, Colorado, Stati Uniti
        • 1160.71.0449 Boehringer Ingelheim Investigational Site
      • Denver, Colorado, Stati Uniti
        • 1160.71.0360 Boehringer Ingelheim Investigational Site
      • Denver, Colorado, Stati Uniti
        • 1160.71.0413 Boehringer Ingelheim Investigational Site
      • Fort Collins, Colorado, Stati Uniti
        • 1160.71.0362 Boehringer Ingelheim Investigational Site
    • Connecticut
      • Bridgeport, Connecticut, Stati Uniti
        • 1160.71.0278 Boehringer Ingelheim Investigational Site
      • Guilford, Connecticut, Stati Uniti
        • 1160.71.0482 Boehringer Ingelheim Investigational Site
    • Florida
      • Boynton Beach, Florida, Stati Uniti
        • 1160.71.0382 Boehringer Ingelheim Investigational Site
      • Brandon, Florida, Stati Uniti
        • 1160.71.0056 Boehringer Ingelheim Investigational Site
      • Clearwater, Florida, Stati Uniti
        • 1160.71.0296 Boehringer Ingelheim Investigational Site
      • Coral Springs, Florida, Stati Uniti
        • 1160.71.0327 Boehringer Ingelheim Investigational Site
      • Daytona Beach, Florida, Stati Uniti
        • 1160.71.0376 Boehringer Ingelheim Investigational Site
      • Fort Myers, Florida, Stati Uniti
        • 1160.71.0074 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Stati Uniti
        • 1160.71.0089 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Stati Uniti
        • 1160.71.0232 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Stati Uniti
        • 1160.71.0427 Boehringer Ingelheim Investigational Site
      • Lakeland, Florida, Stati Uniti
        • 1160.71.0012 Boehringer Ingelheim Investigational Site
      • Miami, Florida, Stati Uniti
        • 1160.71.0034 Boehringer Ingelheim Investigational Site
      • Orlando, Florida, Stati Uniti
        • 1160.71.0227 Boehringer Ingelheim Investigational Site
      • Ormond Beach, Florida, Stati Uniti
        • 1160.71.0095 Boehringer Ingelheim Investigational Site
      • Pensacola, Florida, Stati Uniti
        • 1160.71.0037 Boehringer Ingelheim Investigational Site
      • Port Charlotte, Florida, Stati Uniti
        • 1160.71.0137 Boehringer Ingelheim Investigational Site
      • Port Charlotte, Florida, Stati Uniti
        • 1160.71.0417 Boehringer Ingelheim Investigational Site
      • Rockledge, Florida, Stati Uniti
        • 1160.71.0332 Boehringer Ingelheim Investigational Site
      • Sarasota, Florida, Stati Uniti
        • 1160.71.0385 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Florida, Stati Uniti
        • 1160.71.0015 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Florida, Stati Uniti
        • 1160.71.0339 Boehringer Ingelheim Investigational Site
      • Vero Beach, Florida, Stati Uniti
        • 1160.71.0019 Boehringer Ingelheim Investigational Site
    • Georgia
      • Atlanta, Georgia, Stati Uniti
        • 1160.71.0159 Boehringer Ingelheim Investigational Site
      • Augusta, Georgia, Stati Uniti
        • 1160.71.0021 Boehringer Ingelheim Investigational Site
      • Conyers, Georgia, Stati Uniti
        • 1160.71.0161 Boehringer Ingelheim Investigational Site
    • Illinois
      • Cicero, Illinois, Stati Uniti
        • 1160.71.0218 Boehringer Ingelheim Investigational Site
      • Maywood, Illinois, Stati Uniti
        • 1160.71.0438 Boehringer Ingelheim Investigational Site
      • Melrose Park, Illinois, Stati Uniti
        • 1160.71.0331 Boehringer Ingelheim Investigational Site
      • Normal, Illinois, Stati Uniti
        • 1160.71.0364 Boehringer Ingelheim Investigational Site
      • North Chicago, Illinois, Stati Uniti
        • 1160.71.0109 Boehringer Ingelheim Investigational Site
      • Oak Lawn, Illinois, Stati Uniti
        • 1160.71.0152 Boehringer Ingelheim Investigational Site
      • Rockford, Illinois, Stati Uniti
        • 1160.71.0198 Boehringer Ingelheim Investigational Site
      • Winfield, Illinois, Stati Uniti
        • 1160.71.0433 Boehringer Ingelheim Investigational Site
    • Indiana
      • Fort Wayne, Indiana, Stati Uniti
        • 1160.71.0377 Boehringer Ingelheim Investigational Site
      • Indianapolis, Indiana, Stati Uniti
        • 1160.71.0288 Boehringer Ingelheim Investigational Site
      • Indianapolis, Indiana, Stati Uniti
        • 1160.71.0352 Boehringer Ingelheim Investigational Site
      • Indianapolis, Indiana, Stati Uniti
        • 1160.71.0436 Boehringer Ingelheim Investigational Site
      • South Bend, Indiana, Stati Uniti
        • 1160.71.0235 Boehringer Ingelheim Investigational Site
    • Iowa
      • Dubuque, Iowa, Stati Uniti
        • 1160.71.0268 Boehringer Ingelheim Investigational Site
      • West Des Moines, Iowa, Stati Uniti
        • 1160.71.0001 Boehringer Ingelheim Investigational Site
      • West Des Moines, Iowa, Stati Uniti
        • 1160.71.0357 Boehringer Ingelheim Investigational Site
    • Kentucky
      • Lexington, Kentucky, Stati Uniti
        • 1160.71.0422 Boehringer Ingelheim Investigational Site
      • Louisville, Kentucky, Stati Uniti
        • 1160.71.0178 Boehringer Ingelheim Investigational Site
      • Louisville, Kentucky, Stati Uniti
        • 1160.71.0397 Boehringer Ingelheim Investigational Site
      • Owensboro, Kentucky, Stati Uniti
        • 1160.71.0310 Boehringer Ingelheim Investigational Site
    • Louisiana
      • Baton Rouge, Louisiana, Stati Uniti
        • 1160.71.0144 Boehringer Ingelheim Investigational Site
      • Lafayette, Louisiana, Stati Uniti
        • 1160.71.0018 Boehringer Ingelheim Investigational Site
      • New Iberia, Louisiana, Stati Uniti
        • 1160.71.0132 Boehringer Ingelheim Investigational Site
    • Maine
      • Auburn, Maine, Stati Uniti
        • 1160.71.0096 Boehringer Ingelheim Investigational Site
    • Maryland
      • Annapolis, Maryland, Stati Uniti
        • 1160.71.0114 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Stati Uniti
        • 1160.71.0023 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Stati Uniti
        • 1160.71.0047 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Stati Uniti
        • 1160.71.0079 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Stati Uniti
        • 1160.71.0186 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Stati Uniti
        • 1160.71.0194 Boehringer Ingelheim Investigational Site
      • Bel Air, Maryland, Stati Uniti
        • 1160.71.0255 Boehringer Ingelheim Investigational Site
      • Columbia, Maryland, Stati Uniti
        • 1160.71.0398 Boehringer Ingelheim Investigational Site
      • Rockville, Maryland, Stati Uniti
        • 1160.71.0177 Boehringer Ingelheim Investigational Site
      • Salisbury, Maryland, Stati Uniti
        • 1160.71.0073 Boehringer Ingelheim Investigational Site
      • Salisbury, Maryland, Stati Uniti
        • 1160.71.0207 Boehringer Ingelheim Investigational Site
      • Takoma Park, Maryland, Stati Uniti
        • 1160.71.0196 Boehringer Ingelheim Investigational Site
      • Towson, Maryland, Stati Uniti
        • 1160.71.0187 Boehringer Ingelheim Investigational Site
      • Westminster, Maryland, Stati Uniti
        • 1160.71.0052 Boehringer Ingelheim Investigational Site
    • Massachusetts
      • Haverhill, Massachusetts, Stati Uniti
        • 1160.71.0443 Boehringer Ingelheim Investigational Site
      • Haverhill, Massachusetts, Stati Uniti
        • 1160.71.0452 Boehringer Ingelheim Investigational Site
      • Natick, Massachusetts, Stati Uniti
        • 1160.71.0029 Boehringer Ingelheim Investigational Site
      • North Dartmouth, Massachusetts, Stati Uniti
        • 1160.71.0003 Boehringer Ingelheim Investigational Site
      • Worcester, Massachusetts, Stati Uniti
        • 1160.71.0308 Boehringer Ingelheim Investigational Site
    • Michigan
      • Grand Blanc, Michigan, Stati Uniti
        • 1160.71.0154 Boehringer Ingelheim Investigational Site
      • Lapeer, Michigan, Stati Uniti
        • 1160.71.0205 Boehringer Ingelheim Investigational Site
      • Muskegon, Michigan, Stati Uniti
        • 1160.71.0279 Boehringer Ingelheim Investigational Site
      • Petoskey, Michigan, Stati Uniti
        • 1160.71.0445 Boehringer Ingelheim Investigational Site
      • Rochester Hills, Michigan, Stati Uniti
        • 1160.71.0274 Boehringer Ingelheim Investigational Site
      • Saginaw, Michigan, Stati Uniti
        • 1160.71.0165 Boehringer Ingelheim Investigational Site
      • Troy, Michigan, Stati Uniti
        • 1160.71.0020 Boehringer Ingelheim Investigational Site
      • Ypsilanti, Michigan, Stati Uniti
        • 1160.71.0188 Boehringer Ingelheim Investigational Site
    • Minnesota
      • Minneapolis, Minnesota, Stati Uniti
        • 1160.71.0202 Boehringer Ingelheim Investigational Site
      • St. Paul, Minnesota, Stati Uniti
        • 1160.71.0101 Boehringer Ingelheim Investigational Site
    • Mississippi
      • Gulfport, Mississippi, Stati Uniti
        • 1160.71.0086 Boehringer Ingelheim Investigational Site
      • Tupelo, Mississippi, Stati Uniti
        • 1160.71.0119 Boehringer Ingelheim Investigational Site
    • Missouri
      • Columbia, Missouri, Stati Uniti
        • 1160.71.0055 Boehringer Ingelheim Investigational Site
      • Kansas City, Missouri, Stati Uniti
        • 1160.71.0257 Boehringer Ingelheim Investigational Site
      • St. Charles, Missouri, Stati Uniti
        • 1160.71.0336 Boehringer Ingelheim Investigational Site
      • St. Louis, Missouri, Stati Uniti
        • 1160.71.0249 Boehringer Ingelheim Investigational Site
    • Montana
      • Kalispell, Montana, Stati Uniti
        • 1160.71.0027 Boehringer Ingelheim Investigational Site
    • Nebraska
      • Omaha, Nebraska, Stati Uniti
        • 1160.71.0110 Boehringer Ingelheim Investigational Site
    • Nevada
      • Henderson, Nevada, Stati Uniti
        • 1160.71.0346 Boehringer Ingelheim Investigational Site
      • Las Vegas, Nevada, Stati Uniti
        • 1160.71.0430 Boehringer Ingelheim Investigational Site
    • New Jersey
      • Browns Mills, New Jersey, Stati Uniti
        • 1160.71.0142 Boehringer Ingelheim Investigational Site
      • Cherry Hill, New Jersey, Stati Uniti
        • 1160.71.0221 Boehringer Ingelheim Investigational Site
      • Flemington, New Jersey, Stati Uniti
        • 1160.71.0248 Boehringer Ingelheim Investigational Site
      • Oakland, New Jersey, Stati Uniti
        • 1160.71.0478 Boehringer Ingelheim Investigational Site
      • Ocean, New Jersey, Stati Uniti
        • 1160.71.0392 Boehringer Ingelheim Investigational Site
      • Westwood, New Jersey, Stati Uniti
        • 1160.71.0254 Boehringer Ingelheim Investigational Site
      • Woodland Park, New Jersey, Stati Uniti
        • 1160.71.0472 Boehringer Ingelheim Investigational Site
    • New York
      • Albany, New York, Stati Uniti
        • 1160.71.0476 Boehringer Ingelheim Investigational Site
      • Bronx, New York, Stati Uniti
        • 1160.71.0113 Boehringer Ingelheim Investigational Site
      • Bronx, New York, Stati Uniti
        • 1160.71.0281 Boehringer Ingelheim Investigational Site
      • Cortlandt Manor, New York, Stati Uniti
        • 1160.71.0044 Boehringer Ingelheim Investigational Site
      • Mineola, New York, Stati Uniti
        • 1160.71.0229 Boehringer Ingelheim Investigational Site
      • Mineola, New York, Stati Uniti
        • 1160.71.0451 Boehringer Ingelheim Investigational Site
      • New Rochelle, New York, Stati Uniti
        • 1160.71.0183 Boehringer Ingelheim Investigational Site
      • Northport, New York, Stati Uniti
        • 1160.71.0210 Boehringer Ingelheim Investigational Site
      • Poughkeepsie, New York, Stati Uniti
        • 1160.71.0075 Boehringer Ingelheim Investigational Site
      • Troy, New York, Stati Uniti
        • 1160.71.0414 Boehringer Ingelheim Investigational Site
      • Watertown, New York, Stati Uniti
        • 1160.71.0356 Boehringer Ingelheim Investigational Site
      • Yonkers, New York, Stati Uniti
        • 1160.71.0064 Boehringer Ingelheim Investigational Site
    • North Carolina
      • Asheville, North Carolina, Stati Uniti
        • 1160.71.0353 Boehringer Ingelheim Investigational Site
      • Charlotte, North Carolina, Stati Uniti
        • 1160.71.0080 Boehringer Ingelheim Investigational Site
      • Gastonia, North Carolina, Stati Uniti
        • 1160.71.0350 Boehringer Ingelheim Investigational Site
      • High Point, North Carolina, Stati Uniti
        • 1160.71.0173 Boehringer Ingelheim Investigational Site
      • Pinehurst, North Carolina, Stati Uniti
        • 1160.71.0006 Boehringer Ingelheim Investigational Site
      • Statesville, North Carolina, Stati Uniti
        • 1160.71.0002 Boehringer Ingelheim Investigational Site
      • Statesville, North Carolina, Stati Uniti
        • 1160.71.0069 Boehringer Ingelheim Investigational Site
    • North Dakota
      • Grand Forks, North Dakota, Stati Uniti
        • 1160.71.0102 Boehringer Ingelheim Investigational Site
      • Jamestown, North Dakota, Stati Uniti
        • 1160.71.0222 Boehringer Ingelheim Investigational Site
    • Ohio
      • Akron, Ohio, Stati Uniti
        • 1160.71.0203 Boehringer Ingelheim Investigational Site
      • Canal Fulton, Ohio, Stati Uniti
        • 1160.71.0434 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Stati Uniti
        • 1160.71.0402 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Stati Uniti
        • 1160.71.0426 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Stati Uniti
        • 1160.71.0479 Boehringer Ingelheim Investigational Site
      • Cleveland, Ohio, Stati Uniti
        • 1160.71.0263 Boehringer Ingelheim Investigational Site
      • Cleveland, Ohio, Stati Uniti
        • 1160.71.0480 Boehringer Ingelheim Investigational Site
      • Columbus, Ohio, Stati Uniti
        • 1160.71.0267 Boehringer Ingelheim Investigational Site
      • Dayton, Ohio, Stati Uniti
        • 1160.71.0035 Boehringer Ingelheim Investigational Site
      • Fairview Park, Ohio, Stati Uniti
        • 1160.71.0150 Boehringer Ingelheim Investigational Site
      • Kettering, Ohio, Stati Uniti
        • 1160.71.0201 Boehringer Ingelheim Investigational Site
      • Lorain, Ohio, Stati Uniti
        • 1160.71.0223 Boehringer Ingelheim Investigational Site
      • Lyndhurst, Ohio, Stati Uniti
        • 1160.71.0214 Boehringer Ingelheim Investigational Site
      • Sandusky, Ohio, Stati Uniti
        • 1160.71.0275 Boehringer Ingelheim Investigational Site
      • Westlake, Ohio, Stati Uniti
        • 1160.71.0103 Boehringer Ingelheim Investigational Site
    • Oklahoma
      • Tulsa, Oklahoma, Stati Uniti
        • 1160.71.0435 Boehringer Ingelheim Investigational Site
    • Oregon
      • Corvallis, Oregon, Stati Uniti
        • 1160.71.0139 Boehringer Ingelheim Investigational Site
      • Eugene, Oregon, Stati Uniti
        • 1160.71.0325 Boehringer Ingelheim Investigational Site
      • Springfield, Oregon, Stati Uniti
        • 1160.71.0133 Boehringer Ingelheim Investigational Site
    • Pennsylvania
      • Allentown, Pennsylvania, Stati Uniti
        • 1160.71.0301 Boehringer Ingelheim Investigational Site
      • Camp Hill, Pennsylvania, Stati Uniti
        • 1160.71.0295 Boehringer Ingelheim Investigational Site
      • Hershey, Pennsylvania, Stati Uniti
        • 1160.71.0294 Boehringer Ingelheim Investigational Site
      • Jenkintown, Pennsylvania, Stati Uniti
        • 1160.71.0369 Boehringer Ingelheim Investigational Site
      • Lancaster, Pennsylvania, Stati Uniti
        • 1160.71.0431 Boehringer Ingelheim Investigational Site
      • Langhorne, Pennsylvania, Stati Uniti
        • 1160.71.0168 Boehringer Ingelheim Investigational Site
      • Meadowbrook, Pennsylvania, Stati Uniti
        • 1160.71.0293 Boehringer Ingelheim Investigational Site
      • Norristown, Pennsylvania, Stati Uniti
        • 1160.71.0394 Boehringer Ingelheim Investigational Site
      • Pittsburgh, Pennsylvania, Stati Uniti
        • 1160.71.0466 Boehringer Ingelheim Investigational Site
      • Sellersville, Pennsylvania, Stati Uniti
        • 1160.71.0208 Boehringer Ingelheim Investigational Site
      • Uniontown, Pennsylvania, Stati Uniti
        • 1160.71.0465 Boehringer Ingelheim Investigational Site
      • Wynnewood, Pennsylvania, Stati Uniti
        • 1160.71.0032 Boehringer Ingelheim Investigational Site
      • Wyomissing, Pennsylvania, Stati Uniti
        • 1160.71.0067 Boehringer Ingelheim Investigational Site
    • South Carolina
      • Beaufort, South Carolina, Stati Uniti
        • 1160.71.0007 Boehringer Ingelheim Investigational Site
      • Charleston, South Carolina, Stati Uniti
        • 1160.71.0383 Boehringer Ingelheim Investigational Site
      • Greenville, South Carolina, Stati Uniti
        • 1160.71.0313 Boehringer Ingelheim Investigational Site
      • Spartanburg, South Carolina, Stati Uniti
        • 1160.71.0166 Boehringer Ingelheim Investigational Site
      • Summerville, South Carolina, Stati Uniti
        • 1160.71.0008 Boehringer Ingelheim Investigational Site
    • Tennessee
      • Chattanooga, Tennessee, Stati Uniti
        • 1160.71.0084 Boehringer Ingelheim Investigational Site
      • Clinton, Tennessee, Stati Uniti
        • 1160.71.0474 Boehringer Ingelheim Investigational Site
      • Germantown, Tennessee, Stati Uniti
        • 1160.71.0062 Boehringer Ingelheim Investigational Site
      • Johnson City, Tennessee, Stati Uniti
        • 1160.71.0370 Boehringer Ingelheim Investigational Site
      • Nashville, Tennessee, Stati Uniti
        • 1160.71.0395 Boehringer Ingelheim Investigational Site
    • Texas
      • Austin, Texas, Stati Uniti
        • 1160.71.0129 Boehringer Ingelheim Investigational Site
      • Austin, Texas, Stati Uniti
        • 1160.71.0410 Boehringer Ingelheim Investigational Site
      • Dallas, Texas, Stati Uniti
        • 1160.71.0156 Boehringer Ingelheim Investigational Site
      • Fort Worth, Texas, Stati Uniti
        • 1160.71.0315 Boehringer Ingelheim Investigational Site
      • Houston, Texas, Stati Uniti
        • 1160.71.0447 Boehringer Ingelheim Investigational Site
      • Killeen, Texas, Stati Uniti
        • 1160.71.0483 Boehringer Ingelheim Investigational Site
      • Lubbock, Texas, Stati Uniti
        • 1160.71.0335 Boehringer Ingelheim Investigational Site
      • San Antonio, Texas, Stati Uniti
        • 1160.71.0269 Boehringer Ingelheim Investigational Site
      • San Antonio, Texas, Stati Uniti
        • 1160.71.0307 Boehringer Ingelheim Investigational Site
      • San Marcos, Texas, Stati Uniti
        • 1160.71.0285 Boehringer Ingelheim Investigational Site
      • Tyler, Texas, Stati Uniti
        • 1160.71.0367 Boehringer Ingelheim Investigational Site
    • Virginia
      • Charlottesville, Virginia, Stati Uniti
        • 1160.71.0453 Boehringer Ingelheim Investigational Site
      • Chesapeake, Virginia, Stati Uniti
        • 1160.71.0053 Boehringer Ingelheim Investigational Site
      • Fredericksburg, Virginia, Stati Uniti
        • 1160.71.0428 Boehringer Ingelheim Investigational Site
      • Harrisonburg, Virginia, Stati Uniti
        • 1160.71.0311 Boehringer Ingelheim Investigational Site
      • Newport News, Virginia, Stati Uniti
        • 1160.71.0292 Boehringer Ingelheim Investigational Site
      • Salem, Virginia, Stati Uniti
        • 1160.71.0220 Boehringer Ingelheim Investigational Site
      • Suffolk, Virginia, Stati Uniti
        • 1160.71.0224 Boehringer Ingelheim Investigational Site
      • Winchester, Virginia, Stati Uniti
        • 1160.71.0317 Boehringer Ingelheim Investigational Site
    • Washington
      • Bellingham, Washington, Stati Uniti
        • 1160.71.0050 Boehringer Ingelheim Investigational Site
      • Burien, Washington, Stati Uniti
        • 1160.71.0040 Boehringer Ingelheim Investigational Site
      • Spokane, Washington, Stati Uniti
        • 1160.71.0250 Boehringer Ingelheim Investigational Site
      • Tacoma, Washington, Stati Uniti
        • 1160.71.0256 Boehringer Ingelheim Investigational Site
      • Wenatchee, Washington, Stati Uniti
        • 1160.71.0024 Boehringer Ingelheim Investigational Site
    • West Virginia
      • Clarksburg, West Virginia, Stati Uniti
        • 1160.71.0169 Boehringer Ingelheim Investigational Site
      • Huntington, West Virginia, Stati Uniti
        • 1160.71.0365 Boehringer Ingelheim Investigational Site
    • Wisconsin
      • Madison, Wisconsin, Stati Uniti
        • 1160.71.0099 Boehringer Ingelheim Investigational Site
      • Milwaukee, Wisconsin, Stati Uniti
        • 1160.71.0072 Boehringer Ingelheim Investigational Site
      • Milwaukee, Wisconsin, Stati Uniti
        • 1160.71.0461 Boehringer Ingelheim Investigational Site
  • Svezia
      • Göteborg, Svezia
        • 1160.71.1633 Boehringer Ingelheim Investigational Site
      • Malmö, Svezia
        • 1160.71.1627 Boehringer Ingelheim Investigational Site
      • Norrköping, Svezia
        • 1160.71.1625 Boehringer Ingelheim Investigational Site
      • Nässjö, Svezia
        • 1160.71.1628 Boehringer Ingelheim Investigational Site
      • Stockholm, Svezia
        • 1160.71.1626 Boehringer Ingelheim Investigational Site
      • Stockholm, Svezia
        • 1160.71.1634 Boehringer Ingelheim Investigational Site
      • Umeå, Svezia
        • 1160.71.1624 Boehringer Ingelheim Investigational Site
      • Uppsala, Svezia
        • 1160.71.1621 Boehringer Ingelheim Investigational Site
      • Uppsala, Svezia
        • 1160.71.1635 Boehringer Ingelheim Investigational Site
      • Västerås, Svezia
        • 1160.71.1622 Boehringer Ingelheim Investigational Site
      • Örebro, Svezia
        • 1160.71.1623 Boehringer Ingelheim Investigational Site
  • Svizzera
      • Basel, Svizzera
        • 1160.71.1652 Boehringer Ingelheim Investigational Site
      • Bellinzona, Svizzera
        • 1160.71.1655 Boehringer Ingelheim Investigational Site
      • Bern, Svizzera
        • 1160.71.1651 Boehringer Ingelheim Investigational Site
      • Lugano, Svizzera
        • 1160.71.1654 Boehringer Ingelheim Investigational Site
  • Tailandia
      • Bangkok, Tailandia
        • 1160.71.1701 Boehringer Ingelheim Investigational Site
      • Chiang Mai, Tailandia
        • 1160.71.1703 Boehringer Ingelheim Investigational Site
      • Khon Kaen, Tailandia
        • 1160.71.1704 Boehringer Ingelheim Investigational Site
  • Taiwan
      • Changhua, Taiwan
        • 1160.71.1680 Boehringer Ingelheim Investigational Site
      • Hualien, Taiwan
        • 1160.71.1683 Boehringer Ingelheim Investigational Site
      • Kaohsiung, Taiwan
        • 1160.71.1682 Boehringer Ingelheim Investigational Site
      • Taichung, Taiwan
        • 1160.71.1679 Boehringer Ingelheim Investigational Site
      • Tainan, Taiwan
        • 1160.71.1681 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.71.1671 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.71.1672 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.71.1673 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.71.1674 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.71.1675 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.71.1676 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.71.1677 Boehringer Ingelheim Investigational Site
      • Taoyuan, Taiwan
        • 1160.71.1678 Boehringer Ingelheim Investigational Site
  • Ungheria
      • Budapest, Ungheria
        • 1160.71.1011 Boehringer Ingelheim Investigational Site
      • Budapest, Ungheria
        • 1160.71.1012 Boehringer Ingelheim Investigational Site
      • Budapest, Ungheria
        • 1160.71.1013 Boehringer Ingelheim Investigational Site
      • Budapest, Ungheria
        • 1160.71.1014 Boehringer Ingelheim Investigational Site
      • Budapest, Ungheria
        • 1160.71.1015 Boehringer Ingelheim Investigational Site
      • Budapest, Ungheria
        • 1160.71.1016 Boehringer Ingelheim Investigational Site
      • Gyongyos, Ungheria
        • 1160.71.1020 Boehringer Ingelheim Investigational Site
      • Komarom, Ungheria
        • 1160.71.1017 Boehringer Ingelheim Investigational Site
      • Pecs, Ungheria
        • 1160.71.1018 Boehringer Ingelheim Investigational Site

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion criteria:

Participation in RE-LY, requires long term anticoagulation, provides written informed consent

Exclusion criteria:

Permanent discontinuation of dabigatran during RE-LY

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: dabigatran dose 1
dabigatran high dose twice daily
Droga: dabigatran dose 1
dabigatran high dose twice daily
Sperimentale: dabigatran dose 2
dabigatran low dose twice daily
Droga: dabigatran dose 2
dabigatran low dose twice daily

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Major Bleeding, Annualized Rate of Subjects With Major Bleeds
Lasso di tempo: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Major bleeding must have satisfied one or more of the following criteria:

  • Bleeding associated with a reduction in hemoglobin of at least 20 g/L
  • Required transfusion of at least 2 units of blood or packed cells
  • Symptomatic bleeding in a critical area or organ: intraocular, intraspinal, intramuscular with compartment syndrome, retroperitoneal, intra-articular, pericardial, gastrointestinal

Major bleed were classified as life-threatening if they met one or more of the following criteria:

  • Reduction in hemoglobin of at least 50 g/L
  • Transfusion of at least 4 units of blood or packed cells
  • Symptomatic intracranial bleeding, either subdural or intracerebral
  • Associated with hypotension requiring use of intravenous inotropic agents
  • Required surgical intervention to stop bleeding
  • Resulted in death
up to 43 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Stroke, Annualized Rate of Subjects With Stroke
Lasso di tempo: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Stroke was an acute onset of a focal neurological deficit of presumed vascular origin lasting for 24 hours or more or resulting in death. The stroke was categorized as ischemic or hemorrhagic or cause unknown based on computerized tomography (CT), magnetic resonance (MR) scanning or autopsy. Fatal stroke was defined as death from any cause within 30 days of stroke. Severity of stroke was assessed by modified Rankin score at discharge from hospital
up to 43 months
Non CNS Systemic Embolism (SEE), Annualized Rate of Subjects With Non-CNS SEE
Lasso di tempo: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Systemic embolism was an acute vascular occlusion of the extremities or any organ (kidneys, mesenteric arteries, spleen, retina or grafts), and was to be documented by angiography, surgery, scintigraphy, or autopsy.
up to 43 months
Pulmonary Embolism (PE), Annualized Rate of Subjects With PE
Lasso di tempo: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Pulmonary Embolism was generally documented by one of the following:

  1. an intraluminal filling defect in segmental or more proximal branches on spiral CT scan
  2. an intraluminal filling defect or an extension of an existing defect or a sudden cutoff of vessels more than 2.5 mm in diameter on the pulmonary angiogram
  3. a perfusion defect of at least 75% of a segment with a local normal ventilation result (high-probability) on ventilation/perfusion lung scan (VPLS)
  4. inconclusive spiral CT, pulmonary angiography or lung scintigraphy with demonstration of DVT in the lower extremities by compression ultrasound or venography.
up to 43 months
Acute Myocardial Infarction (MI), Annualized Rate of Subjects With MI
Lasso di tempo: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

a. In subjects not undergoing PCI or CABG a subject should have fulfilled at least 2 of the following: i. Typical prolonged severe chest pain or related symptoms or signs suggestive of MI. ii. Elevation of troponin or CK-MB to more than upper level of normal (ULN) or, if CK-MB was elevated at baseline, re-elevation to more than 50% increase above the previous level. iii. Development of significant Q-waves in at least 2 adjacent ECG leads. b. After percutaneous coronary intervention (within 24h). c. After coronary artery bypass grafting (within 72h). d. Silent myocardial infarction. e. Myocardial infarction could also have been demonstrated at autopsy.
up to 43 months
Deep Vein Thrombosis, Annualized Rate of Subjects With DVT
Lasso di tempo: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Deep Vein Thrombosis (DVT) was generally documented by one of the following:

  1. abnormal compression ultrasound (CUS),
  2. an intraluminal filling defect on venography.
up to 43 months
Death, Annualized Rate of Subject Death
Lasso di tempo: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Deaths were classified as being vascular (sudden/arrhythmic, pump failure death, or other vascular, including bleeding) or non-vascular, due to other specified causes (e.g., malignancy), or of unknown etiology.
up to 43 months
Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE)
Lasso di tempo: up to 43 months
Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
up to 43 months
Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE) and All Cause Death
Lasso di tempo: up to 43 months
Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
up to 43 months
Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE), Pulmonary Embolism (PE), Myocardial Infarction, Vascular Death
Lasso di tempo: up to 43 months
Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
up to 43 months
Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE), Pulmonary Embolism (PE), Myocardial Infarction (MI), All Cause Death and Major Bleed
Lasso di tempo: up to 43 months
Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
up to 43 months
Annualized Rate of Subjects With Minor Bleeds
Lasso di tempo: up to 43 months

Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.

Minor bleeds were clinical bleeds that did not fulfill the criteria for major bleeds. Minor bleeds were classified as associated with study medication discontinuation (temporary or permanent) or not.
up to 43 months
Annualized Rate of Subjects With Any Bleeds (Major Plus Minor)
Lasso di tempo: up to 43 months
Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
up to 43 months
Annualized Rate of Subjects With Intra-Cranial Hemorrhage (ICH)
Lasso di tempo: up to 43 months
Annualized event rate (%) = 100 * No. subjects with event / subject-years. Subject-years = Sum (date of last visit - date of first dose + 1) of all subjects / 365.25.
up to 43 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Boehringer Ingelheim

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Collegamenti utili

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio

1 novembre 2008

Completamento primario (Effettivo)

1 dicembre 2012

Completamento dello studio (Effettivo)

1 dicembre 2012

Date di iscrizione allo studio

Primo inviato

12 dicembre 2008

Primo inviato che soddisfa i criteri di controllo qualità

12 dicembre 2008

Primo Inserito (Stima)

15 dicembre 2008

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Stima)

9 giugno 2014

Ultimo aggiornamento inviato che soddisfa i criteri QC

3 giugno 2014

Ultimo verificato

1 marzo 2014

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • 1160.71
  • 2008-005248-17 (Numero EudraCT: EudraCT)

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi